Harmony Biosciences ( NASDAQ: HRMY ) priced previously announced underwritten public offering of 8M shares at a public offering price of $31.00 per share. The selling shareholders have granted the underwriter a 30-day option to purchase an additional 1.
2M shares. The company is not.